Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:BTG NASDAQ:IRWD NYSE:RIG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTGB2Gold$3.65-0.3%$4.34$3.31▼$6.28$4.82B0.6632.45 million shs13.86 million shsIRWDIronwood Pharmaceuticals$3.90+0.6%$3.85$0.71▼$5.78$633.49M0.23.41 million shs927,032 shsRIGTransocean$5.12-0.1%$5.88$2.59▼$7.66$5.72B1.339.77 million shs23.67 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTGB2Gold-3.68%-5.18%-19.91%-26.80%+6.09%IRWDIronwood Pharmaceuticals-3.25%-17.13%+5.74%-12.64%+423.19%RIGTransocean-1.54%-0.18%-8.24%-13.65%+100.59%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTGB2Gold$3.65-0.3%$4.34$3.31▼$6.28$4.82B0.6632.45 million shs13.86 million shsIRWDIronwood Pharmaceuticals$3.90+0.6%$3.85$0.71▼$5.78$633.49M0.23.41 million shs927,032 shsRIGTransocean$5.12-0.1%$5.88$2.59▼$7.66$5.72B1.339.77 million shs23.67 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTGB2Gold-3.68%-5.18%-19.91%-26.80%+6.09%IRWDIronwood Pharmaceuticals-3.25%-17.13%+5.74%-12.64%+423.19%RIGTransocean-1.54%-0.18%-8.24%-13.65%+100.59%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTGB2Gold 2.25Hold$5.5050.68% UpsideIRWDIronwood Pharmaceuticals 2.71Moderate Buy$6.2360.03% UpsideRIGTransocean 2.00Hold$6.8233.36% UpsideCurrent Analyst Ratings BreakdownLatest RIG, BTG, and IRWD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2026BTGB2Gold Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$5.75 ➝ $5.007/8/2026RIGTransocean SusquehannaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetPositive$8.00 ➝ $7.007/6/2026BTGB2Gold Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$7.00 ➝ $6.007/1/2026IRWDIronwood Pharmaceuticals Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/7/2026RIGTransocean BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$6.00 ➝ $8.005/6/2026RIGTransocean TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$5.50 ➝ $6.004/27/2026IRWDIronwood Pharmaceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)4/21/2026RIGTransocean Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 7/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTGB2Gold$3.06B1.58$0.75 per share4.84$2.72 per share1.34IRWDIronwood Pharmaceuticals$296.15M2.14$0.25 per share15.54($1.61) per share-2.42RIGTransocean$3.97B1.44$0.66 per share7.70$7.36 per share0.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTGB2Gold$401.91M-$0.0310.143.320.3014.91%21.36%13.13%8/6/2026 (Estimated)IRWDIronwood Pharmaceuticals$24.02M$0.606.48N/AN/A28.26%-39.65%26.54%8/6/2026 (Estimated)RIGTransocean-$2.92B-$2.98N/A19.67N/A-66.79%0.88%0.46%8/5/2026 (Estimated)Latest RIG, BTG, and IRWD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026BTGB2Gold$0.08N/AN/AN/A$879.44 millionN/A8/6/2026Q2 2026IRWDIronwood Pharmaceuticals$0.26N/AN/AN/A$116.97 millionN/A8/5/2026Q2 2026RIGTransocean$0.01N/AN/AN/A$954.18 millionN/A5/7/2026Q1 2026IRWDIronwood Pharmaceuticals$0.2467$0.24-$0.0067$0.24$92.11 million$106.51 million5/6/2026Q1 2026BTGB2Gold$0.11$0.19+$0.08N/A$893.41 million$1.16 billion5/4/2026Q1 2026RIGTransocean$0.07-$0.03-$0.10$0.06$1.02 billion$1.08 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBTGB2Gold$0.082.19%N/AN/A N/AIRWDIronwood PharmaceuticalsN/AN/AN/AN/AN/ARIGTransoceanN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTGB2Gold0.131.190.59IRWDIronwood PharmaceuticalsN/A1.411.41RIGTransocean0.601.541.20Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTGB2Gold61.40%IRWDIronwood PharmaceuticalsN/ARIGTransocean67.73%Insider OwnershipCompanyInsider OwnershipBTGB2Gold1.18%IRWDIronwood Pharmaceuticals9.30%RIGTransocean9.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTGB2Gold6,3271.32 billion1.31 billionNot OptionableIRWDIronwood Pharmaceuticals220163.06 million147.89 millionOptionableRIGTransocean5,6001.12 billion1.01 billionOptionableRIG, BTG, and IRWD HeadlinesRecent News About These CompaniesAnalysts Set Transocean Ltd. (NYSE:RIG) Price Target at $6.82July 17 at 4:58 AM | americanbankingnews.comNEVADA KING RECEIVES BLM APPROVAL FOR 482 ADDITIONAL DRILL SITES, ADDS THIRD DRILL RIG TO ACCELERATE FULLY FUNDED 40,000M DRILL PROGRAMJuly 16 at 7:00 AM | prnewswire.comTransocean (RIG): Buy, Sell, or Hold Post Q1 Earnings?July 14 at 9:23 AM | finance.yahoo.comTransocean Ltd. (NYSE:RIG) Receives Average Rating of "Hold" from AnalystsJuly 12, 2026 | marketbeat.comSG Americas Securities LLC Trims Stock Holdings in Transocean Ltd. $RIGJuly 10, 2026 | marketbeat.comRIG: A Cash Gusher At A Marked-Down PriceJuly 10, 2026 | trefis.comTTransocean and Noble Corporation shares are soaring, what you need to knowJuly 8, 2026 | msn.comWhy Does Transocean (NYSE:RIG) Stand Out in the S&P 500 Energy Sector?July 8, 2026 | kalkinemedia.comKTransocean (NYSE:RIG) Director Buys 35,000 SharesJuly 8, 2026 | insidertrades.comTransocean Ltd. Announces Second Quarter 2026 Earnings Release DateJuly 7, 2026 | finance.yahoo.comTransocean Ltd. to Report Second Quarter 2026 Earnings and Fleet Status on August 5July 7, 2026 | quiverquant.comQTransocean Ltd. Announces Second Quarter 2026 Earnings Release DateJuly 7, 2026 | globenewswire.comStrategic Deals Boost EQNR's Offshore Operations & Production GrowthJuly 6, 2026 | finance.yahoo.comTransocean forecasts $3.85B-$4B revenue in 2025 amid high fleet utilizationJuly 6, 2026 | msn.comFideuram Intesa Sanpaolo Private Banking S.P.A. Has $17.22 Million Stock Holdings in Transocean Ltd. $RIGJuly 3, 2026 | marketbeat.comTransocean Ltd. (RIG) Secures $1B Contract with Equinor for Harsh-Environment RigsJuly 2, 2026 | finance.yahoo.comTransocean Ltd. (RIG) Secures $1B Contract with Equinor for Harsh-Environment RigsJuly 2, 2026 | insidermonkey.comQ2 Earnings Forecast for Transocean Issued By Zacks ResearchJuly 2, 2026 | marketbeat.comTransocean Signs $1 Billion Deal for Rigs from EquinorJuly 2, 2026 | marketwatch.comEquinor (OB:EQNR) Exits Japan Wind And Backs Norway With $1 Billion Rig DealJuly 1, 2026 | finance.yahoo.com5 Most Buzzing Stocks to Buy Right NowJuly 1, 2026 | insidermonkey.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesApple’s Intel Deal Arrives at the Right Time for Its StockBy Sam Quirke | June 23, 2026IQM's Nasdaq Debut Could Change the Quantum Race for D-WaveBy Nathan Reiff | July 10, 2026The Quantum Bubble Is Real Enough to Take SeriouslyBy Nathan Reiff | June 30, 2026SpaceX Has Real Value—But These 3 Stocks Have Better Odds Right NowBy Bridget Bennett | June 28, 2026AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?By Jessica Mitacek | June 26, 2026RIG, BTG, and IRWD Company DescriptionsB2Gold NYSEAMERICAN:BTG$3.65 -0.01 (-0.27%) As of 02:34 PM EasternB2Gold Corp. operates as a gold producer company. It operates the Fekola Mine in Mali, the Masbate Mine in the Philippines, and the Otjikoto Mine in Namibia. The company also has an 100% interest in the Gramalote gold project in Colombia; 24% interest in the Calibre Mining Corp.; and approximately 19% interest in BeMetals Corp. In addition, it has a portfolio of other evaluation and exploration assets in Mali and Finland. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.Ironwood Pharmaceuticals NASDAQ:IRWD$3.90 +0.03 (+0.65%) As of 02:53 PM Eastern This is a fair market value price provided by Massive. Learn more.Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, Saudi Arabia, and China, as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; Apraglutide, a next-generation, long-acting synthetic peptide analog of glucagon-like peptide-2, as a differentiated therapeutic for rare diseases, including short bowel syndrome dependent on parenteral support and acute graft versus host disease; and CNP-104, an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.Transocean NYSE:RIG$5.12 -0.01 (-0.10%) As of 02:53 PM Eastern This is a fair market value price provided by Massive. Learn more.Transocean Ltd., together with its subsidiaries, provides offshore contract drilling services for oil and gas wells worldwide. It contracts mobile offshore drilling rigs, related equipment, and work crews to drill oil and gas wells. The company operates a fleet of mobile offshore drilling units, consisting of ultra-deepwater floaters and harsh environment floaters. It serves integrated energy companies, government-owned or government-controlled energy companies, and other independent energy companies. The company was founded in 1926 and is based in Steinhausen, Switzerland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident GE Aerospace Faces a Prove-It Moment in Q2 Earnings Sandisk: What the Chart Is Trying to Tell Us Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Has Broadcom Become Too Expensive for Its AI Story? 3 Picks-and-Shovels Stocks Powering the Humanoid Robotics Buildout J.B. Hunt Stock Could Reach $340 as Trucking Capacity Shrinks The AI Data Center Boom Is Bigger Than One Stock—These ETFs Spread the Bet Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
